Contains fulltext : 107753.pdf (publisher's version ) (Open Access)BACKGROUND: Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac function and poor exercise tolerance. Enhanced inflammation is associated with worsening outcomes in HF patients and may play a direct role in disease progression. Interleukin-1beta (IL-1beta) is a pro-inflammatory cytokine that becomes chronically elevated in HF and exerts putative negative inotropic effects. METHODS AND RESULTS: We developed a model of IL-1beta-induced left ventricular (LV) dysfunction in healthy mice that exhibited a 32% reduction in LV fractional shortening (P<0.001) and a 76% reduction in isoproterenol response (P<0.01) at 4 hours following ...
Item does not contain fulltextPatients with heart failure (HF) have enhanced systemic IL-1 activity,...
Background: Recent studies on the pathophysiology of heart failure indicate the role of neurohormone...
Background Enhanced inflammation may lead to exercise intolerance in heart failure with preserved ej...
BACKGROUND: Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac func...
Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac function and poo...
<div><h3>Background</h3><p>Heart failure (HF) is a complex clinical syndrome characterized by impair...
Background: Interleukin 1β (IL 1β) levels are associated with prognosis in heart failure. The cardia...
Contains fulltext : 174762.pdf (publisher's version ) (Open Access)Support measure...
Over the past 50 years, the understanding of the deteriorative changes involved in the progression o...
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome of exercise intoleranc...
Contains fulltext : 110810.pdf (publisher's version ) (Open Access)OBJECTIVE: Rece...
Heart Failure (HF) is a clinical syndrome characterized by dyspnea, fatigue, and poor exercise capa...
Background: Interleukin-1 (IL-1) is an inflammatory cytokine that responds as an acute phase reactan...
Item does not contain fulltextOBJECTIVE: Treatment of viral fulminant myocarditis relies on life sup...
Heart failure (HF) is a leading cause of mortality. Inflammation is implicated in HF, yet clinical t...
Item does not contain fulltextPatients with heart failure (HF) have enhanced systemic IL-1 activity,...
Background: Recent studies on the pathophysiology of heart failure indicate the role of neurohormone...
Background Enhanced inflammation may lead to exercise intolerance in heart failure with preserved ej...
BACKGROUND: Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac func...
Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac function and poo...
<div><h3>Background</h3><p>Heart failure (HF) is a complex clinical syndrome characterized by impair...
Background: Interleukin 1β (IL 1β) levels are associated with prognosis in heart failure. The cardia...
Contains fulltext : 174762.pdf (publisher's version ) (Open Access)Support measure...
Over the past 50 years, the understanding of the deteriorative changes involved in the progression o...
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome of exercise intoleranc...
Contains fulltext : 110810.pdf (publisher's version ) (Open Access)OBJECTIVE: Rece...
Heart Failure (HF) is a clinical syndrome characterized by dyspnea, fatigue, and poor exercise capa...
Background: Interleukin-1 (IL-1) is an inflammatory cytokine that responds as an acute phase reactan...
Item does not contain fulltextOBJECTIVE: Treatment of viral fulminant myocarditis relies on life sup...
Heart failure (HF) is a leading cause of mortality. Inflammation is implicated in HF, yet clinical t...
Item does not contain fulltextPatients with heart failure (HF) have enhanced systemic IL-1 activity,...
Background: Recent studies on the pathophysiology of heart failure indicate the role of neurohormone...
Background Enhanced inflammation may lead to exercise intolerance in heart failure with preserved ej...